Blue Lake Biotechnology

Startup

Blue Lake Biotechnology, Inc. is developing intranasal vaccines that harness the full breadth of the immune system to keep people healthy and prevent serious infectious diseases. Our platform uses a proprietary parainfluenza virus 5 vector into which a foreign gene from a targeted pathogen is inserted. We have generated a robust clinical-stage pipeline of best-in-class vaccines designed to overcome the limitations of existing vaccine technologies. Our lead product candidates have demonstrated potential for high efficacy and durability with few vaccine-related side effects. We aspire to transform the healthcare landscape with better vaccines that are painless, easy to use, and effective.